Terms: = Germ cell tumor AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3
84560 results:
1. First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors.
Li W; Wang Y; Xiong A; Gao G; Song Z; Zhang Y; Huang D; Ye F; Wang Q; Li Z; Liu J; Xu C; Sun Y; Liu X; Zhou F; Zhou C
Signal Transduct Target Ther; 2024 Nov; 9(1):300. PubMed ID: 39489747
[TBL] [Abstract] [Full Text] [Related]
2. Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers.
Xu T; Dillon JS; Maluccio MA; Quelle DE; Nash SH; Cho H; Limbach KE; Skill NJ; Bren-Mattison Y; O'Rorke MA
J Cancer Res Clin Oncol; 2024 Nov; 150(11):485. PubMed ID: 39488644
[TBL] [Abstract] [Full Text] [Related]
3. Promoting application of enhanced recovery after surgery protocols during perioperative localized abdominal and thoracic neuroblastomas.
He J; Wang Z; Yu X; Su Y; Hong M; Zhu K
Pediatr Surg Int; 2024 Nov; 40(1):286. PubMed ID: 39487870
[TBL] [Abstract] [Full Text] [Related]
4. Patient-reported outcome and preference after craniotomy and laser interstitial thermal therapy ablation: a pilot study.
Peña Pino I; Bartek J; Ben-Haim S; Chen CC
Neurosurg Focus; 2024 Nov; 57(5):E7. PubMed ID: 39486062
[TBL] [Abstract] [Full Text] [Related]
5. Evaluating laser interstitial thermal therapy for newly diagnosed, deep-seated, large-volume glioblastoma: survival and outcome analysis.
Khalafallah AM; Shah KH; Knott MV; Berke CN; Shah AH; Komotar RJ; Ivan ME
Neurosurg Focus; 2024 Nov; 57(5):E3. PubMed ID: 39486051
[TBL] [Abstract] [Full Text] [Related]
6. Unexpected Radioiodine Uptake in 131I Whole-Body Scan: A Case of Ovarian Mature Teratoma.
Yang B; Lv Y; Zhang X; Shao F; Lan X
Clin Nucl Med; 2024 Dec; 49(12):e710-e711. PubMed ID: 39485878
[TBL] [Abstract] [Full Text] [Related]
7. New emerging treatment options for metastatic melanoma: a systematic review and meta-analysis of skin cancer therapies.
Jarab AS; Al-Qerem WA; Khdour LM; Mimi YA; Khdour MR
Arch Dermatol Res; 2024 Nov; 316(10):735. PubMed ID: 39485529
[TBL] [Abstract] [Full Text] [Related]
8. Growth velocity of fetal sacrococcygeal teratoma as predictor of perinatal morbidity and mortality: multicenter study.
Vinit N; Benachi A; Rosenblatt J; Jouannic JM; Rousseau V; Bonnard A; Irtan S; Fouquet V; Ville Y; Khen-Dunlop N; Lapillonne A; Jais JP; Beaudoin S; Salomon LJ; Sarnacki S
Ultrasound Obstet Gynecol; 2024 Nov; 64(5):651-660. PubMed ID: 39482803
[TBL] [Abstract] [Full Text] [Related]
9. [Histopathological diagnosis of pulmonary sclerosing pneumocytoma in needle biopsy specimens].
Si QQ; Han J; Gao XZ; Zang YY; Wang TL; Li SL
Zhonghua Bing Li Xue Za Zhi; 2024 Nov; 53(11):1105-1110. PubMed ID: 39482047
[No Abstract] [Full Text] [Related]
10. Amide proton transfer-weighted CEST MRI for radiotherapy target delineation of glioblastoma: a prospective pilot study.
Tang PLY; Romero AM; Nout RA; van Rij C; Slagter C; Swaak-Kragten AT; Smits M; Warnert EAH
Eur Radiol Exp; 2024 Oct; 8(1):123. PubMed ID: 39477835
[TBL] [Abstract] [Full Text] [Related]
11. Adipsic arginine vasopressin deficiency: challenges in managing the intricate interplay of adipsia with polyuria.
Malik A; Singh R; Goyal A; Gupta R
BMJ Case Rep; 2024 Oct; 17(10):. PubMed ID: 39477460
[TBL] [Abstract] [Full Text] [Related]
12. Association Between Multisystem Immune-related Adverse Events and Progression-free Survivals in PD-1/PD-L1 Inhibitor Monotherapy.
Yamaguchi A; Saito Y; Okamoto K; Furugen A; Narumi K; Takekuma Y; Sakakibara-Konishi J; Shimizu Y; Kinoshita I; Sugawara M; Kobayashi M
In Vivo; 2024; 38(6):2886-2896. PubMed ID: 39477436
[TBL] [Abstract] [Full Text] [Related]
13. Correlation of Psychosomatic Factors and Personality Traits With the Severity of Melanoma.
Kontoangelos K; Nikolaou V; Syrgianni A; Tsiori S; Papageorgiou C; Stratigos A
In Vivo; 2024; 38(6):2844-2852. PubMed ID: 39477397
[TBL] [Abstract] [Full Text] [Related]
14.
Képes Z; Szabó JP; Kálmán-Szabó I; Sass T; Esze R; Opposits G; Jószai I; Szikra D; Fenyvesi F; Hajdu I; Trencsényi G
In Vivo; 2024; 38(6):2591-2600. PubMed ID: 39477386
[TBL] [Abstract] [Full Text] [Related]
15. The Diagnostic Potential of Extracellular Vesicles Derived From the Blood Plasma of Glioblastoma Patients.
Döring K; Malinova V; Bettag C; Rohde V; Schulz M; Menck K; Bleckmann A; Binder C; Büntzel J
In Vivo; 2024; 38(6):2735-2739. PubMed ID: 39477379
[TBL] [Abstract] [Full Text] [Related]
16. Monocarboxylate transporter dependent mechanism is involved in proliferation, migration, and invasion of human glioblastoma cell lines via activation of PI3K/Akt signaling pathway.
Gao C; Yang B; Li Y; Pei W
PLoS One; 2024; 19(10):e0312939. PubMed ID: 39475905
[TBL] [Abstract] [Full Text] [Related]
17. Measuring the diagnostic management and follow-up imaging for glioma patients across Belgian hospitals between 2016 and 2019.
Vanhauwaert D; Vanschoenbeek K; Weyns F; Vanopdenbosch L; Tieleman A; Michotte A; Goffin K; De Gendt C; De Vleeschouwer S; Boterberg T
Cancer Med; 2024 Nov; 13(21):e70045. PubMed ID: 39475180
[TBL] [Abstract] [Full Text] [Related]
18. BRAF inhibitor candidate molecule usnic acid might use both intrinsic and extrinsic pathways of apoptosis.
Büyük BP; Cansaran Duman D; Duman T
Turk J Med Sci; 2024; 54(5):1116-1126. PubMed ID: 39473730
[TBL] [Abstract] [Full Text] [Related]
19. HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to tumor Growth by Activating the Transcription of
Xu G; Sun J; Wei L; Yi X; Han F; Liu W
Front Biosci (Landmark Ed); 2024 Sep; 29(10):341. PubMed ID: 39473408
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of insulinoma-associated protein 1 (INSM1) with traditional neuroendocrine markers in gastrointestinal and pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs).
Gao R; Zhang X; Chen X; Lin Y; Jin L; Zheng H; Yu X
Diagn Pathol; 2024 Oct; 19(1):144. PubMed ID: 39472993
[TBL] [Abstract] [Full Text] [Related]
[Next]